Boston Biomedical continues to build on its unique strengths of examining the molecular mechanisms that promote the generation of abnormal cells, which leads to tumor formation, and how these aberrant cells move and change shape. By discovering how cells normally respond to protein signals and how they migrate, Boston Biomedical’s Cancer Initiative can better identify the components of faulty signaling pathways that contribute to cancer onset and progression. Boston Biomedical’s discovery efforts focused on how to impede tumor development and the spread of cancer cells to other areas of the body are critical in the development of new effective oncology therapeutics.